Evidence map›Paper›PMID 39427106›Full record

ReviewPharmaceutical medicine2024

Addressing Challenges in Antibiotic Access: Barriers, Implications and Strategies for Solution.

Ritika Kondel Bhandari, Avaneesh Kumar Pandey, Samir Malhotra, Ashish Kumar Kakkar, Sanjeev Singh, Jennifer Cohn, Alison Holmes, Esmita Charani, Nusrat Shafiq

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pharmaceutical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. A Codesigned Approach to Develop Tailored Antimicrobial Stewardship Strategies in Bangladesh: A Social-Ecological Systems Framework Analysis.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ritika Kondel Bhandari *Clinical Pharmacology Unit, Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Avaneesh Kumar Pandey *Clinical Pharmacology Unit, Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Samir MalhotraClinical Pharmacology Unit, Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Ashish Kumar KakkarClinical Pharmacology Unit, Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Sanjeev SinghDepartment of Medical Administration, Amrita Insitute of Medical Sciences and Research Centre, AMRITA Hospitals, Faridabad, India.
Jennifer CohnGlobal Antibiotic Research and Development Partnership, Geneva, Switzerland.
Alison HolmesDepartment of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom.
Esmita CharaniDivision of Infectious Diseases and HIV Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa. esmita.charani@uct.ac.za.
Nusrat ShafiqClinical Pharmacology Unit, Department of Pharmacology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. nusrat.shafiq.pgi@gmail.com.

Funding

Wellcome Trust 225960/Z/22Wellcome Trust 226690/Z/22/ZWellcome Trust 310518/Z/24/Z
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) poses a significant threat to global public health, disproportionately affecting low- and middle-income countries (LMICs). While excessive antibiotic use is often discussed, the issue of access to antibiotics demands attention. This viewpoint explores the multidimensional nature of the issue of access to antibiotics. We have examined the issue through the lens of social, economic, healthcare structures, manufacturing and supply chain, policy and practices. Inter-relatedness of these issues has also been explored. The review further discusses potential solutions involving but not limited to increased awareness, improvement in healthcare infrastructure, models for sustained manufacturing and supply chains. Additionally, enhancing antimicrobial stewardship at hospital and community levels, empowering healthcare professionals, and emphasizing infection prevention are crucial. Global initiatives that aim to address access challenges, emphasizing collaboration and innovation are important to foster for a sustained response to the issue of antibiotic access.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipHealth Services AccessibilityDeveloping CountriesDrug Resistance, MicrobialGlobal HealthHumansPublic HealthAnti-Bacterial Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.